According to the company's published materials, compounded medications may be offered when FDA-approved medications are unavailable due to shortages, when a patient has a documented allergy to an inactive ingredient in an FDA-approved version, when a different dosage form is determined appropriate by the evaluating clinician, or when otherwise deemed medically necessary by the healthcare provider
This comes at a time when clinics are already under financial strain, preparing for an estimated 1.3 million to 3.4 million Californians to lose their Medi-Cal because of federal work requirements and more frequent redeterminations [1]
No specific trial is named behind either set of numbers, and the ranges differ from those used in other posts on the same site
Upregulated p53-Ser15 phosphorylation (p53-pS15) was identified as a key marker
Eur Rev Med Pharmacol Sci (2019) 23(5):190714
B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial